SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
IVF reported Third Quarter 2026 results. The price and volatility reaction is pending.
IVFearnings

Earnings reactions, page 2

INVO Fertility, Inc. (IVF) Q3 FY2026 earnings

November 16, 2026 · SharpeIQ Research Desk

Reported results

  • Total revenue increased to $2,222,656 from $1,757,094 in the prior-year quarter.
  • Consolidated clinic revenue increased to $2,207,587 from $1,722,223 in the prior-year quarter.
  • Net loss narrowed to $2,149,920 from $3,395,598 in the prior-year quarter.
  • Consolidated Adjusted EBITDA was $(961,704) compared to $(947,568) in the prior-year quarter.
  • Clinic-Level Adjusted EBITDA was $292,114 compared to $243,120 in the prior-year quarter.

Notes

Clinic-Level Adjusted EBITDA is a non-GAAP measure. Fertility Clinic Services Segment data derived from Note 15 – Segment Reporting in the Company’s third quarter 10-Q.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-11-16 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →